患有与肥胖有关的心力衰竭患者的身体组成与保存的喷射分数:一项比较研究
Hannah Salmons1, Syed Imran Ahmed1, Hayley E Billingsley1
1Department of Kinesiology & Health Sciences, College of Humanities & Sciences, Virginia Commonwealth University, Richmond, Virginia, USA.
JPEN. Journal of parenteral and enteral nutrition
|September 20, 2025
概括
分段单频生物电阻分析 (SF-BIA) 准确地评估了与肥胖相关的心力衰竭患者的身体组成,其中包括保存的喷射分数 (HFpEF). 这种方法是DXA的可靠替代方案,用于诊断缩症和缩性肥胖症.
科学领域:
- 心脏病学 心脏病学
- 身体组成分析 身体成分分析
- 肥胖问题研究研究
背景情况:
- 尾肌瘦质量指数 (ALMI) 对于心肺健康和诊断肥胖相关心力衰竭与保留射出分数 (HFpEF) 中的萨尔科佩尼亚至关重要.
- 准确的身体成分评估对于管理肥胖的HFpEF患者至关重要.
研究的目的:
- 为了验证细分单频生物电阻分析 (SF-BIA) 与双能X射线吸收计 (DXA) 进行对照,以评估身体组成.
- 具体评估SF-BIA在测量尾肌肉质量指数 (ALMI) 的准确性,以诊断肥胖的HFpEF患者的麻症.
主要方法:
- 对62名患有肥胖相关HFpEF的evolemic患者的分析.
- 通过细分SF-BIA和DXA获得的身体组成测量的比较.
主要成果:
- 细分SF-BIA在ALMI (r=0.897) 和其他身体组成参数 (r=0.8520.970) 中与DXA显示出强烈的相关性.
- 在SF-BIA和DXA之间没有观察到显著的比例偏差,除了附脂肪质量指数.
结论:
- 分段SF-BIA提供与肥胖HFpEF患者的DXA相当的准确的身体组成评估.
- 细分SF-BIA是这个患者群体中身体组成分析和肉类症诊断的推工具.
相关概念视频
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734
Heart Failure VII: Nursing Interventions
422
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
422
Heart Failure I: Introduction
710
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
710
Heart Failure III: Clinical Manifestations
511
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
511
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261


